Tradestie Institutional Equity Comparison Engine
IMNN vs GRML โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IMNN Overall Edge
IMNN Captures Institutional Edge (2โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Imunon, Inc. Common Stock (IMNN) driven by superior Valuation, Growth & Margin while GRML counters with relative strength in Momentum & Technical. Fundamentally, IMNN trades at 16.8x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus GRML at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, IMNN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GRML sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
IMNN
IMNN 16.8x vs GRML N/M Fwd P/E
Growth & Margin Winner
IMNN
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
GRML
1Y -86.5% vs +650.0% ยท 52W Pos 2% vs 19%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
IMNN
NASDAQ
Imunon, Inc. Common Stock
Pharmaceutical Preparations
$0.56
-10.95% 1D
Market Cap
$3.6M
1M Return
-45.09%
1Y Return
-86.54%
Forward P/E
16.8x
Unified AI Score
32.2 / 100
SELL
Tech 25.0
Fund 42.0
Flow 50.0
Mom 55.0
GRML
US Equity
GRML
Institutional Equity
$3.51
-2.77% 1D
Market Cap
N/A
1M Return
-41.5%
1Y Return
+650.0%
Forward P/E
N/M
Unified AI Score
56.8 / 100
HOLD
Tech 60.0
Fund 57.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IMNN -86.54%
GRML +650.0%
Spread: +732.16 pp (GRML Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
IMNN TTM Op. Margin: 0.0%
GRML TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMNN vs GRML. Trailing 12-month operating profitability (IMNN 0.0% vs GRML N/A) and valuation multiples (IMNN 16.8x vs GRML N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IMNN | GRML | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.6M | N/A | Larger Scale | IMNN |
| Trailing P/E Ratio Valuation | 16.8x | N/M | Lower Multiple | IMNN |
| Forward P/E Ratio Valuation | 16.8x | N/M | Lower Multiple | IMNN |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | IMNN |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | IMNN |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | IMNN |
| Return on Equity (ROE) Capital Efficiency | -429.7% | N/A | Higher ROE | IMNN |
| 52-Week Range Position Momentum | 2% ($0โ$4) | 19% ($0โ$18) | Stronger Trend | GRML |
| Beta / 30D Volatility Risk Regime | 0.44ฮฒ ยท 145% Vol | -5.32ฮฒ ยท 95% Vol | Lower Realized Risk | GRML |
| Unified Institutional Score Composite Signal | 32.2 / 100 (SELL) | 56.8 / 100 (HOLD) | Higher Composite | GRML |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IMNN vs GRML Buy Guide
IMNN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GRML
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IMNN nor GRML registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.